Abstract
The new enantiomerically pure 3-substituted-Delta(2)-isoxazolin-5-yl-ethanolamines
(+)-6a/(-)-6b, (-)-6a/(+)-6b, and (+)-7a/(-)-7b, prepared via a 1,3-dipolar
cycloaddition-based approach, were tested for their affinity at human
beta(1)-, beta(2)-, and beta(3)-adrenergic receptor (beta-AR) subtypes
stably expressed in CHO cells. The corresponding 3-isopropenyl derivatives
(+)-5a/(-)-5b, (-)-5a/(+)-5b, and some isoxazole analogs were also
tested. The binding affinities at the beta-ARs of the isoxazolinyl
amino alcohols were significantly lower than those of the corresponding
isoxazole derivatives. A stereochemical effect was observed, since
the process of molecular recognition is predominantly controlled
by the (S)-configuration of the stereogenic center located at the
5 position of the heterocycle rather than by that of the stereocenter
carrying the secondary alcohol group. On the contrary, the stereochemical
features marginally affected the efficacy response; as a matter of
fact, functional tests carried out on Delta(2)-isoxazoline derivatives
provided with a detectable binding affinity showed the overall profile
of neutral antagonists at all three beta-AR subtypes.
Users
Please
log in to take part in the discussion (add own reviews or comments).